Document is current
Any future updates will be listed below
-
Authors
Liu, Sa
Liu, Jiaqin
Su, Nan
Wei, Shanshan
Xie, Ning
Li, Xiangyun
Xie, Suifen
Liu, Jian
Zhang, Bikui
Li, Wenqun
Tan, Shengyu https://orcid.org/0009-0007-5163-9508
-
Funding
Funding for this research was provided by:
Innovative Research Group Project of the National Natural Science Foundation of China (81973406, 82173911, 82373970)
Fundamental Research Funds for Central Universities of the Central South University (2022ZZTS0243, 2022ZZTS0954)
Natural Science Foundation of Hunan Province (2020JJ4823, 2020jj80109)
Health and Family Planning Commission of Hunan Province (202113050843)
Chinese Pharmaceutical Association Hospital Pharmacy department (CPA-Z05-ZC-2021-002)
Changsha Science and Technology Project (kq2004137)
Chinese Anti- Cancer Association HER2 target Chinese Research Fund (CORP-239-S5)
- License Information
-
More Information
Article History
Accepted: 16 January 2024
First Online: 24 February 2024
Declarations
:
: All the procedures in this study were performed in accordance with the National Institutes of Health Guide (NIH Publications No. 8023) for the Care and Use of Laboratory Animals. The experimental protocol (ethics approval number: CSU-2022–0260, commencement date: April 22, 2022) has been approved by the Medicine Animal Welfare Committee of Xiangya School of Medicine (License number: SYXK-2020–0019). This paper is based on a study involving publicly available data, which is exempt from ethical review. It was approved by the Ethics Committee of Second Xiangya Hospital.
: The authors give full consent for publication.
: Not applicable.
: The authors declare no conflict of interest.
